Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Ingram

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Oncotarget|April 9, 2016
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasisMilene Volpato, Sarah L Perry, Gemma Marston, et al.
Lab on a Chip|September 13, 2012
Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubblesSally A Peyman, Radwa H Abou-Saleh, James R McLaughlan, et al.
ACS Applied Bio Materials|January 12, 2022
Freeze-Dried Therapeutic Microbubbles: Stability and Gas ExchangeRadwa H Abou-Saleh, Aileen Delaney, Nicola Ingram, et al.
Scientific Reports|July 22, 2017
Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc <sup>Min/+</sup> mouse model of intestinal tumorigenesisMark A Hull, Richard J Cuthbert, C W Stanley Ko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 24, 2021
Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4Antonia Charalambous, Victoria Mico, Laura E McVeigh, et al.
Molecular Cancer|February 16, 2011
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancerSampoorna Satheesha, Victoria J Cookson, Louise J Coleman, et al.
Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Theranostics|October 12, 2020
Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissuesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Elife|June 28, 2017
Affimer proteins are versatile and renewable affinity reagentsChristian Tiede, Robert Bedford, Sophie J Heseltine, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Oncotarget|April 9, 2016
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasisMilene Volpato, Sarah L Perry, Gemma Marston, et al.
Lab on a Chip|September 13, 2012
Expanding 3D geometry for enhanced on-chip microbubble production and single step formation of liposome modified microbubblesSally A Peyman, Radwa H Abou-Saleh, James R McLaughlan, et al.
ACS Applied Bio Materials|January 12, 2022
Freeze-Dried Therapeutic Microbubbles: Stability and Gas ExchangeRadwa H Abou-Saleh, Aileen Delaney, Nicola Ingram, et al.
Scientific Reports|July 22, 2017
Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc <sup>Min/+</sup> mouse model of intestinal tumorigenesisMark A Hull, Richard J Cuthbert, C W Stanley Ko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 24, 2021
Targeted microbubbles carrying lipid-oil-nanodroplets for ultrasound-triggered delivery of the hydrophobic drug, combretastatin A4Antonia Charalambous, Victoria Mico, Laura E McVeigh, et al.
Molecular Cancer|February 16, 2011
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancerSampoorna Satheesha, Victoria J Cookson, Louise J Coleman, et al.
Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Theranostics|October 12, 2020
Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissuesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Elife|June 28, 2017
Affimer proteins are versatile and renewable affinity reagentsChristian Tiede, Robert Bedford, Sophie J Heseltine, et al.
Pageof 4